EZ-Med Technologies

Butterfly Medical (formerly EZ-Med Technologies) is an Israeli medical device company focused on developing a minimally invasive treatment for Benign Prostatic Hyperplasia (BPH). The company's core technology is a nitinol-based prostatic implant designed to dilate the prostatic urethra and alleviate lower urinary tract symptoms (LUTS). Unlike traditional surgical procedures, the Butterfly device is designed for a simple, office-based insertion under local anesthesia, offering a reversible and less traumatic alternative for patients. The device has received CE Mark approval and is currently undergoing a pivotal clinical trial in the United States to support FDA clearance. By providing a mechanical solution that bridges the gap between pharmaceutical therapy and invasive surgery, Butterfly Medical aims to improve the quality of life for millions of men suffering from BPH.